all those biotechs are kind of in a pickle.
some good Conference calls from management, and never a word about a reverse split.
I think they are expecting a partner before that to push them to above a dollar.
Mixed bag if that partnership happens too soon, because the PIII trial is cheap, fast and easy to populate with hot flash women and I would hope the company wouldn't give up the farm on a cheaper than necessary partnership just to stay listed.
Of course there is an appeal the company can make that gives them six more months.
ERHE is OTCBB and I don't think that's necessarily the reason why it sucks so hard right now. (I just bought more today at $.39 to average down--which I hate to say that word)
Comparing GNVC to BNVI, I absolutely think they are comparable with similar futures, but right now if I was buying either one, I would probably put 2/3 in BNV just to buy more shares and 1/3 in GNVC keeping dry powder if it falls to $1.50
only my opinion lugs, but wtf do I know I've bought ERHE twice in the last 10 days.
robj
News 
Market Data 
Discover 
AI
